• Founded in 2008
  • Employees: 10

Description :

VAXIMM is a Swiss- and Germany-based biotech company that is developing oral T-cell vaccines as immunotherapy for patients suffering from cancer.

Headquarters :

Elisabethenstrasse 3 4051 Basel

Related Posts

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.